series-b
Stage
4
Investors
About
DefiniGEN uses stem cell technology and artificial intelligence to produce human cell lines for research and drug development.
Explore DefiniGEN's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.